Age of Onset of Polycystic Ovarian Syndrome in Girls May Be Earlier Than Previously Thought

被引:42
作者
Bronstein, Jason [1 ]
Tawdekar, Sonali [1 ]
Liu, Yinghua [1 ]
Pawelczak, Melissa [1 ]
David, Raphael [1 ]
Shah, Bina [1 ]
机构
[1] NYU, Dept Pediat, Ctr Med, Sch Med,Div Pediat Endocrinol, New York, NY 10016 USA
关键词
Polycystic ovary syndrome; Adolescents; Hyperandrogenism; PREMATURE PUBARCHE; METABOLIC SYNDROME; YOUNG-WOMEN; ANDROGEN LEVELS; INSULIN-RESISTANCE; CHILDHOOD OBESITY; ADOLESCENT GIRLS; BLOOD-PRESSURE; METFORMIN; RISK;
D O I
10.1016/j.jpag.2010.06.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To study the age at diagnosis of polycystic ovarian syndrome (PCOS) in a pediatric population. To compare risk factors involved in causing PCOS in preadolescent and adolescent girls. To review the current literature on the reported age of PCOS in girls. Design: A retrospective chart review and systematic review of the literature. Participants: Patients included 58 girls (age <= 18 yrs) with a diagnosis of PCOS based on the Rotterdam criteria. Girls were grouped as preadolescents (<13 yrs) or adolescents (13-18 yrs). Clinical and biochemical data were reviewed from the time of diagnosis. Main Outcome Measures: Age at diagnosis. Differences in risk factors for PCOS (Ethnicity, obesity, family history of PCOS, birth weight, age at pubarche, thelarche and menarche, evidence of hyperandrogenism and/or insulin resistance) were compared between the two groups. Results: There were 26% (15/58) preadolescent girls (9-12 yrs) vs 74% (43/58) adolescents (13-18 yrs). There was no significant difference between the two groups in ethnicity, BMI z-score, family history of maternal PCOS, birth weight, hyperandrogenism, or insulin resistance. Preadolescents with PCOS had significantly earlier onset of pubarche and thelarche than adolescents with PCOS, by 1.9 and 1.5 yrs, respectively (P = 0.018, 0.030). In addition to earlier puberty, PCOS developed 2.1 years sooner after thelarche in preadolescents than in adolescents. (P = 0.008) Preadolescents were significantly taller for age than adolescents (72nd % vs 43rd %) (P = 0.005). A review of the 28 studies published in the last 3 years that included PCOS patients with age <=18 yrs described only 6.4% (27/425) of pediatric subjects with age <13 yrs. Four were primarily pediatric studies that included patients under the age of 13 yrs, with 9.4% (12/127) of the patients <13 yrs. Conclusion. Increased awareness of PCOS in young females is needed. PCOS may occur at a younger age in girls who develop early pubarche and thelarche. Therefore, the diagnosis and workup should be considered in young girls with risk factors suggestive of PCOS.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 52 条
[1]   Lipoprotein(a) levels in girls with premature adrenarche [J].
Andiran, Nesibe ;
Yordam, Nursen .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2008, 44 (03) :138-142
[2]   OVARIAN HYPERANDROGYNISM AS A RESULT OF CONGENITAL ADRENAL VIRILIZING DISORDERS - EVIDENCE FOR PERINATAL MASCULINIZATION OF NEUROENDOCRINE FUNCTION IN WOMEN [J].
BARNES, RB ;
ROSENFIELD, RL ;
EHRMANN, DA ;
CARA, JF ;
CUTTLER, L ;
LEVITSKY, LL ;
ROSENTHAL, IM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) :1328-1333
[3]   Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study [J].
Battaglia, C ;
Regnani, G ;
Mancini, F ;
Iughetti, L ;
Flamigni, C ;
Venturoli, S .
HUMAN REPRODUCTION, 2002, 17 (03) :771-776
[4]   Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria [J].
Bhattacharya, Sudhindra M. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2008, 34 (01) :62-66
[5]   Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome [J].
Bridger, T ;
MacDonald, S ;
Baltzer, F ;
Rodd, C .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (03) :241-246
[6]  
Broder-Fingert Sarabeth, 2009, J Clin Res Pediatr Endocrinol, V1, P188, DOI 10.4274/jcrpe.v1i4.50
[7]   Pubertal development in children and adolescents born after IVF and spontaneous conception [J].
Ceelen, Manon ;
van Weissenbruch, Mirjam M. ;
Vermeiden, Jan P. W. ;
van Leeuwen, Flora E. ;
Delemarre-van de Waal, Henriette A. .
HUMAN REPRODUCTION, 2008, 23 (12) :2791-2798
[8]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[9]   Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome [J].
Chen, Mei-Jou ;
Yang, Wei-Shiung ;
Yang, Jehn-Hsiahn ;
Chen, Chi-Ling ;
Ho, Hong-Nerng ;
Yang, Yu-Shih .
HYPERTENSION, 2007, 49 (06) :1442-1447
[10]   Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance [J].
Coviello, AD ;
Legro, RS ;
Dunaif, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :492-497